ClinicalTrials.gov record
Terminated Phase 2 Interventional

Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease

ClinicalTrials.gov ID: NCT04987294

Public ClinicalTrials.gov record NCT04987294. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 2:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled Study of ALLN-346 (Engineered Urate Oxidase) in Hyperuricemic Subjects With Gout and Mild to Moderate Chronic Kidney Disease

Study identification

NCT ID
NCT04987294
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Allena Pharmaceuticals
Industry
Enrollment
19 participants

Conditions and interventions

Interventions

  • ALLN-346 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 1, 2022
Primary completion
Sep 1, 2022
Completion
Sep 1, 2022
Last update posted
Jun 22, 2023

2022

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
15
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Syed Research Consultants, LLC Muscle Shoals Alabama 35661
Syed Research Consultants, LLC Sheffield Alabama 35660
Orthopedic Physicians Alaska Anchorage Alaska 99508
Allameh Medical Corporation Mission Viejo California 92691
Eastern Research, Inc. Hialeah Florida 33013
Best Quality Research, Inc. Hialeah Florida 33016
New Generation of Medical Research Hialeah Florida 33016
Kendall South Medical Center, Inc. Miami Florida 33185
The Center of Rheumatology and Bone Research Wheaton Maryland 20902
Elite Clinical Research, LLC Jackson Mississippi 39202
NY Total Medical Care, PC Brooklyn New York 11215
Burke Primary Care Morganton North Carolina 28655
Summit research Group, LLC Stow Ohio 44224
Northeast Clinical Research Center, LLC Bethlehem Pennsylvania 18017
P&I Clinical Research, LLC Lufkin Texas 75904
Briggs Clinical Research, LLC San Antonio Texas 78224

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04987294, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 22, 2023 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04987294 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →